Effectiveness of a Cognitive Training Program (UMAM Method) in Elderly People Without Dementia

Sponsor
Madrid Salud (Other)
Overall Status
Completed
CT.gov ID
NCT04245579
Collaborator
Universidad Complutense de Madrid (Other), Hospital San Carlos, Madrid (Other), Centro de Tecnología Biomédica, Madrid (Other)
199
1
2
19
10.5

Study Details

Study Description

Brief Summary

The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia. On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g. educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention. The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: Multifactorial Memory Training Program (UMAM method)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
199 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Cognitive Training in Elders Without Dementia Using UMAM Method. Genetic, Brain Volume and Cognitive Reserve Predictors: A Randomized Controlled Study
Actual Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
May 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

The experimental group carried out a 30-session multi-factorial group memory training program (UMAM method), with a frequency of three weekly sessions of 90 minutes each. The training program consists of four modules: 1- Stimulation of cognitive processes; learning and practicing internal memory strategies and solving everyday forgetfulness; 2- Instruction in basic concepts about memory; 3- Intervention on daily living and forgetting experiences, using internal and external strategies to solve everyday memory failures; 4- Metacognition or metamemory: the subjects were to reflect about their cognitive failures by analyzing the causes and variables of those failures. In addition, the experimental group followed the standard activities in which all users attending the Center are involved (planned interviews, dialogue-conferences, general health recommendations, etc.).

Other: Multifactorial Memory Training Program (UMAM method)

No Intervention: Control Group

The Control Group followed the standard activities in which all users attending the Center are involved (planned interviews, dialogue-conferences, general health recommendations, etc.).

Outcome Measures

Primary Outcome Measures

  1. Change in general cognition [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in general cognition, assessed with the Mini Mental State Examination Test (MMSE) and the 7 Minutes Test (7M).The score ranges from 0 to 30 points (MMSE) and from 0 to 89 points (7M). In both cases, the higher scores indicate a better outcome.

  2. Change in verbal memory [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in verbal memory, assessed with the Word List Test of the Wechsler Memory Scale-III. The score ranges from 0 to 48 points. Higher scores indicate a better outcome.

  3. Change in logical memory [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in immediate and delayed logical memory, assessed with the Logical Memory Test (immediate and delayed units) of the Wechsler Memory Scale-III. The score ranges from 0 to 75 points (immediate units) and from 0 to 50 (delayed units). Higher scores indicate a better outcome.

  4. Change in visual memory [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in visual memory, assessed with the Rey memory test (form B). The score ranges from 0 to 22 points. Higher scores indicate a better outcome.

  5. Change in daily memory [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in daily memory, assessed with the Rivermead Behavioral Memory Test. The score ranges from 0 to 24 points. Higher scores indicate a better outcome.

  6. Change in attentional amplitude [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in attentional amplitude, assessed with the Direct Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 16 points. Higher scores indicate a better outcome.

  7. Change in attentional control [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in attentional control, assessed with the Inverse Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 14 points. Higher scores indicate a better outcome.

  8. Change in attention and processing speed [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in attention, assessed with the Trail Making Test, form A. The score ranges from 0 to 200 points. Higher scores indicate a worse outcome.

  9. Change in alternating attention and planning [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in alternating attention and planning, assessed with the Trail Making Test, form B. The score ranges from 0 to 400 points. Higher scores indicate a worse outcome.

  10. Change in naming ability (language) [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in naming ability, assessed with the Boston Naming Test. The score ranges from 0 to 60 points. Higher scores indicate a better outcome.

  11. Change in verbal fluency (language) [This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in phonologic and semantic verbal fluency, assessed with the Phonological Verbal Fluency Test and the Semantic Fluency Test respectively. The score goes from zero onwards (there is no upper limit). Higher scores indicate a better outcome.

  12. Change in subjective memory [This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in Subjective Memory, assessed with the Memory Failures of Everyday Questionnaire.The score ranges from 0 to 56 points. Higher scores indicate a worse outcome.

  13. Change in mood [This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.]

    The measure of the post-intervention change in mood, assessed with the Geriatric Depression Scale. The score ranges from 0 to 15 points. Higher scores indicate a worse outcome.

  14. The Cognitive Reserve as a predictor of change. [Cognitive Reserve was assessed in the pre-intervention assessment.]

    The Cognitive Reserve was assessed with Rami Test. The score ranges from 0 to 25 points.

  15. The Genetic Profile as a predictor of change. [The Genetic Profile was assessed in the pre-intervention assessment.]

    The Genetic Profile was obtained by genetic analysis employing a blood test. APOE gene has been coded as 1 (meaning no ε4 allele), or 0 (for at least one ε4 allele).

  16. The Brain Volume as a predictor of change. [The Brain Volume was assessed in the pre-intervention assessment.]

    The Brain Volume (total gray volume, left hippocampus, right hippocampus and total intracranial volume) was assessed by magnetic resonance imaging. Unit of measure: mm3.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being over 60 years old.

  • Having a global cognitive performance > 23 in the Mini Mental State Examination Test.

  • Having no history of neurological or serious psychiatric disorders (severe psycho-affective disorders and psychosis or other psychiatric disorders like alcoholism).

Exclusion Criteria:
  • Chronic use of anxiolytics.

  • Chronic use of neuroleptics.

  • Chronic use of anticonvulsants.

  • Having hearing or vision impairments that would preclude testing.

  • Magnetic Resonance Imaging (MRI) contraindications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro de Prevención del Deterioro Cognitivo Madrid Spain 28006

Sponsors and Collaborators

  • Madrid Salud
  • Universidad Complutense de Madrid
  • Hospital San Carlos, Madrid
  • Centro de Tecnología Biomédica, Madrid

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Madrid Salud
ClinicalTrials.gov Identifier:
NCT04245579
Other Study ID Numbers:
  • 15/382-E_BS
First Posted:
Jan 29, 2020
Last Update Posted:
Jan 29, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Madrid Salud
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2020